Status:
WITHDRAWN
Analgesic Effect of Pregabalin in Patients Undergoing Total Abdominal Hysterectomy
Lead Sponsor:
Northwestern University
Conditions:
Pain
Eligibility:
FEMALE
18-64 years
Phase:
NA
Brief Summary
Pregabalin will decrease the total amount of opioid required in patients undergoing total abdominal hysterectomy. In addition, pregabalin will decrease the incidence of opioid-related side effects in ...
Eligibility Criteria
Inclusion
- ASA Physical Status 1-2
- Age 18-64
- BMI 18-35
- Scheduled for elective total abdominal hysterectomy (with or without bilateral salpingo-oophorectomy)
- Gender: Female
- Consent: Obtained
Exclusion
- Patient refusal
- Allergy to study medication(s)
- Preoperative use of gabapentinoids
- Preoperative use of anticonvulsants
- Daily use of analgesics
- Hepatic disease
- Renal insufficiency (Cr \>2.0)
- Alcohol or drug abuse
- Pregnancy
- Language: Non-English speaking
- Patient expected to remain intubated after procedure
- Dropout:
- Patient request
- Surgeon request
- Allergic reaction to pregabalin
- Surgical procedure significantly altered from scheduled procedure
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01466101
Start Date
January 1 2011
Last Update
February 20 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.